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MUTATIONS IN PROTHROMBIN AND FACTOR V
GENES DO NOT CONTRIBUTE SIGNIFICANTLY
TO PLACENTAL VASCULOPATHY IN A HIGH-RISK
PATIENT COHORT IN SOUTH AFRICA
To the Editor: During normal pregnancy there are dramatic
changes in the coagulation and fibrinolytic systems. There is
deposition of fibrin in the uteroplacental walls and fibrinolysis
is suppressed. An increase in levels of clotting factors VII, vrn
and X and a doubling in the levels of fibrinogen are observed.
The end result is the well-described hypercoagulability of
pregnancy, protecting the mother against blood loss at delivery,
but also predisposing her to possible thrombotic complications.
Naturally occurring anticoagulants including antithrombin III
and the protein C-thrombomodulin-protein S complex protect
against generalised thrombosis. Protein C (with its co-factors
protein S and thrombomodulin) inactivates factors V and vrn.
Abnormal forms of factor V, such as those arising from DNA
mutation, resist such inactivation and thrombosis can result.
The association between placental infarcts and adverse
pregnancy outcome, especially midtrimester pregnancy loss
and the development of pre-eclampsia, is well described in the
antiphospholipid syndrome. Progressive thrombosis and
infarcts in the placenta predispose to pregnancy complications
such as intrauterine growth restriction (IUGR), pre-eclampsia
and abruptio placentae. It is therefore reasonable to anticipate
that other forms of thrombophilia could lead to adverse
pregnancy outcome.
One such inherited condition is activated protein C
resistance (APCR). Coagulation factorY (FV) acts as co-factor
for activated factor X to activate prothrombin in the
coagulation cascade. FV is normally cleaved by protein C
rendering it inactivated. The gene encoding human FV contains
25 exons (ranging from 72 to 2820 base pair (bp) in size) and
spans more than 80 kilobase pair (kb). A mutation in exon 10
(A1691G) of the gene was described,! which results in the
substitution of an arginine with a glycine residue and abolishes
the site of protein C cleavage. This variant was named the FV
Leiden mutation, after the city in which it was discovered.
The association between FV Leiden mutation and pre-
eclampsia was first reported in a small patient cohort with
severe early-onset pre-eclampsia.' In a larger study' of 158
women with severe pre-eclampsia, a mutation frequency of
8.9% was reported compared with a control group frequency of
4.2% (x' = 4.686, P = 0.03). All patients were heterozygous for
the mutation.' Since then several contradictory reports
regarding this apparent association have appeared in the
literature.
In 1996, a g ---7 a transition at position 20210 of the 3'
untranslated region of the gene encoding prothrombin was
described. This mutation (G20210A) could be associated with
elevated plasma prothrombin levels and an increased risk of
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venous thrombosis.' Subsequently, independent associations
with pre-eclampsia were reported, including a study of 110
women with serious pregnancy complications (abruptio
placentae, severe pre-eclampsia, and IUGR). The incidence of
the G20210A mutation was reported to be 10% compared with
3% in a control panel (P < 0.03).' However, globally the
frequency of this mutation (and that of FV Leiden)
demonstrates strong population specificity.
Within the venous thrombosis patient population of the
Western Cape region of South Africa, the frequency of the FV
Leiden mutation is 26% among whites, 8% in coloureds (mixed
ancestry) and apparently absent in black South Africans." The
frequency of the prothrombin mutation in unknown. -
The broad spectrum of mutation frequency within different
populations together with the high incidence of placental
vasculopathy in the study cohort prompted an investigation
into the contribution of these mutations to pre-eclampsia in the
pregnant population in the Western Cape. The three study
groups comprised 50 primi- and 50 multigravida women ",ith:
(i) early onset severe pre-eclampsia; (ii) late onset pre-
eclampsia; or (iii) pregnancy-induced hypertension. A further
50 women ffith abruptio placentae and a control group (50
individuals ffith uncomplicated pregnancy outcome) were also
included.
Heterozygosity for FV Leiden and the G20210A prothrombin
gene mutation was identified in 5 (1.4%) and
2 (0.6%) patients, respectively (Table D. No homozygote mutant
status could be demonstrated. No mutation was detected in
any indi\idual in the control group. All mutation-positive
patients had an uneventful postpartum course and none
developed any sign of thrombotic complication.
The incidence of the thrombotic mutations is extremely rare
in the population studied suggesting that it is not a significant
contributing factor in the development of pre-eclampsia.
Antenatal screening for inherited thrombophilia in these
patients (coloured and black South Africans) is therefore not
warranted. It remains to be seen whether these mutations are
more common in white South Africans with pre-eclampsia.
The contribution of inherited thrombophilia to placental
infarctions and pre-eclampsia suggests that there may be other,
as yet unknown, underlying hypercoagulability factors that
play a role in these conditions. It may also imply that the real
cause of placental vasculopathy lies elsewhere, and that a
tendency to increased clotting only urunasks this condition
earlier in susceptible patients.
The authors thank Erika van Papendorp for her diligent and
untiring help in recruiting patients for the study. The University of
Stellenbosch and the Medical Research Council are gratefully
acknowledged for their support. R Hillermann is a recipient of a
post-doctoral fellowship at the University of Stellenbosch.
Disease-association studies are usually more significant when
carried out on well-stratified patients from a homogeneous
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Table I. Demographic details of mutation-positive patients. A total of 400 individuals were screened for the presence of these mutations.
Age
.(yrs) Race History Mutation Complication
Cigarette
smoker
Gestation
at
delivery
(weeks)
Birth
mass
(g)
36
26
30
20
28
17
19
C
C
C
C
C
C
B
G4P2
G3P2
G2P1
G1PO
G1PO
G1PO
G1PO
A1691G PE No 36
A1691G PE Yes 40
A1691G AP TO 30
A1691G AP 0 34
A1691G Pili 0 41
G20210A Severe PE Yes 30
G20210A Severe PE 10 32
3794
3260
1394
1250
2306
1208
1722
c ~ coloured/mixed ancestry; B~ black African; G =gravida; P ~ para; PE ~ pre-eclampsia; AP ~ abruptio placentae; PlH ~ pregnancy-induced hypertension; A1691G ~ factor V
L-eiden mutation; G20210A = prothrombin mutation.
population. Characterising sequence variants in the LDLR gene in
the South African Afrikaner population is an example. Pre-
eclampsia affects women of all ethnic groups, but for this study
mainly coloured (representing San, Khoi, African Negro,
Madagascan, Javanese and Western European origins) patients,
who fall within our hospital catchment area, were included.
Restricting the analysis to a single group should therefore increase
the resolution/power of the study.
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TRYPANOSOMIASIS - AN UNUSUAL CAUSE OF
REVERSIBLE MULTIPLE ORGAN DYSFUNCTION
IN SOUTH AFRICA
To the Editor: It is recogrlised that American trypanosomiasis
or Chagas' disease causes morbidity and mortality among poor
people in developing countries, but it is not as widely
recognised as it should be in Europe and the USA. l A similar
argument applies to African trypanosomiasis, where bites from
the t~etse fly can transmit the Brucei gambiense from western
central Africa or rhodesiel1se from eastern southern Africa, with
the latter form progressing more rapidly through febrile illness
to meningoencephalitis.'-'
A recently encountered case of trypanosomiasis is reported
with life-threatening multiple organ dysfunction.
A 56-year-old woman from the USA had been bitten on the
lower leg while visiting a game reserve in Tanzania. She had
arrived in Africa via airobi, and travelled through various
game reserves in Kenya and Tanzania. On board a cruise ship
from Mombasa to Cape Town she became severely ill with a
septic ulcer on her ankle, the site of the bite, and subsequently
with pyrexia and a skin rash. The skin lesion was treated
topically and the ship's doctor gave her intravenous UV)
ceftriaxone.
There was no apparent past medical history and she had
been on mefloquine for malaria prophylaxis. Her condition
deteriorated and on arrival in Cape Town she was admitted to
hospital with a septicaemic illness characterised by high fever
and a diffuse purpuric rash over her entire body.
Although initially conscious, she rapidly became confused
and stuporous and renal function deteriorated, with creatinine
rising to 450 )lIDol/l. Respiratory distress developed, as did
clinical jaundice, with biochemical evidence of acute hepatitis.
Even though a tropical disease was suspected the initial
diagnosis was a rickettsial illness. Her full blood count showed
features of a disseminated intravascular coagulation (DIe) ""ith
thrombocytopenia but routine microscopic examination of the
peripheral blood slide by the haematologist fortuitously
identified large numbers of trypanosomes (Fig. 1).
After extensive consultation suramin sodium' was obtained
and commenced within 24 hours of the diagnosis. Further
literature also confirmed usefulness of pentamadine'"' and this
was added to her regimen but discontinued after 5 days.
The patient's condition deteriorated and she was transferred
to another hospital for further management. Because of the
notoriously bad prognosis of this disease and from previous
experience with severe malaria, it was decided to continue
Fig. 1. TnJPanosoma. Peripheral blood, May-Gn"inwald stain, x 1 000 oil.
treatment with IV suramin but to introduce plasma exchange'·'·
to increase clearance of the parasite and toxins from the blood.
Shortly after transfer adult respiratory distress syndrome
developed. The patient required ventilation as well as
continuous haemodialysis (CWHD) for deteriorating renal
failure.
After about 10 days she started improving, her lungs
cleared and she was weaned off ventilation. Her urine output
improved and dialysis was reduced and then stopped. Mental
state rapidly returned to normal.
Although a lumbar puncture was not done initially,
cerebrospinal fluid (CSF) on day 13 of treatment was abnormal
with a protein of 0.73 g/l, 13 lymphocytes and 18 red blood
cells per microlitre. No trypanosomes were seen in the CSF.
The ulcer on the leg remained large and purulent with
central necrosis and required surgical debridement, but
thereafter it began to heal, although final skin closure did
require a small skin graft.
It is concluded that there is a need for greater awareness of
the risk of serious tropical diseases manifesting after touring in
tropical countries.
We acknowledge Or John O'Brien for referring the patient and
initial excellent clinical management. We thank Professor Ema
Mansvelt from Tygerberg Hospital for the photomicrographs.
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SYMPTOMS OF THE BITE OF AN ORB-WEB
SPIDER ARANEUS APRICUS (ARANEAE:
ARANEIDAE)
To the Editor: Research on the toxicity of southern African
spiders has concentrated mainly on species of known
venomous genera, namely the button spiders Latrodectus
(Theridiidae), the sac spiders Chiiracanthillm (Miturgidae), the
violin spiders Loxosceles and the six-eyed crab spiders Sicarius
(both Sicariidae).
Spider venom can be categorised into three main types'
based on the general symptoms effected: cytotoxic venom,
which causes swelling and formation of lesions; neurotoxic
venom, which affects the transport of neural impulses and
consequently cardiovascular, respiratory and muscular
functioning; and haemotoxic venom, which causes degradation
of blood cells. The venom of some species of the aforemen-
tioned genera is severely toxic; in some Sicarius species it is
cyto- and haemotoxic and in Latrodectus indistictus 0 p-
Cambridge it is neurotoxic so that a bite may be fat31 to
humans/2 although no fatalities have been reported yet. The
effects of the venom of cytotoxic spiders have been extensively
studied/.J·'.J while the venom characteristics and symptoms of
the button spiders and their relatives have also received
attention.',J Here the symptoms of the bite of an orb-web
spider, Araneus apricus (Karsch) (Araneae: Araneidae), are
briefly described.
Arboreal spiders were collected from dense subtropical bush
in the dumu Game Reserve in northern KwaZulu-Natal
during July 2000 using the beating and hand-to-jar methods.
An adult female A. apricus specimen collected proved to be
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Fig. 1: A male Araneus apricus spider on a leaf (photo courtesy of
John Leroy).
very aggressive and bit the collector, a healthy 21-year-old
male, dorsally on the knuckle of the thumb of the right hand.
She kept her fangs locked and was allowed to bite for 27
seconds as araneid spiders are not known to be venomous to
humans. After relaxing her fangs the spider was removed and
preserved in 70% ethanol for identification. It must be noted
that the victim is severely allergic to bee stings, but had
undergone a course of antivenom to develop immunity.
The reactions to the venom were as follows. The bite was not
especially painful, but the pressure of the fangs could be felt
while the bite was inflicted, as well as mild pain in the thumb
and surrounding areas immediately following envenomation.
Soon afterwards local swelling and red dermal colouration
around the bite site developed, with the thumb and forefinger
area becoming numb. Within the first hour sharp pain
developed in the bicep, armpit, shoulder, lateral chest and
pectoral muscles, after which discomfort levels decreased.
Lymph glands in the armpit also started to swell during this
time. Intense pain began developing in the thumb and index
finger an hour after envenomation, and continued during the
subsequent hours.
Local swelling around the bite site gradually increased to an
area approximately 2.5 cm in diameter, which was bright red in
colour and extremely itchy. Swelling of the hand and armpit
glands receded within 8 hours of the bite. A small scar formed
at the site of the bite marks, which healed after 16 days
(without any treatment), and no tissue necrosis occurred.
The A. apriClls female collected had a bright lime-green oval
abdomen and reddish cephalothorax with cream-coloured
setae, and the typical Araneus body shape. The spider was
deposited as a voucher specimen in the National Collection of
Arachnida, Agricultural Research Council (ARC) Plant
Protection Research Institute, Pretoria. Orb-weavers collected
from northern KwaZulu- atal fitting the above description are
likely to be this particular species. This species has a wide
distribution in north-eastern South Africa, and has been
collected from Telspruit, Letaba (where it is common in citrus,
macadarnia and avocado orchards), Acornhoek, Nylsvlei,
Naboomspruit, the Kruger National Park, and in gardens in
Pretoria, Johannesburg and Rustenburg (Dr Ansie Dippenaar-
Schoeman - personal communication). It is therefore found in
close association "vith humans on farms, in gardens and in
rural areas and the possibility of bites occurring does exist.
Observations at Ndumu in July and November/December
2000 showed that the species is much more abundant in
summer months and will more likely be encountered at this
time. A. apricus appears to be largely restricted to tree layers
more than 2 m above the ground, but was occasionally
collected in orb webs constructed between shrubs at heights of
1.5 m.
The bite of A. apricl/s cannot be regarded as being as severe
as that of L. indistictus,' and no tissue necrosis resulted from the
bite. The muscular pains caused by A. apricus bites can
probably be relieved using painkillers. It seems unlikely that
antivenom is needed, owing to the mild reaction to the bite.
Many of the signs and symptoms described for L. geometricus C
L Koch2 were experienced in this case, but diagnosis can be
distinguished by a lack of burning at the bite site and shorter
duration and mildness of symptoms in A. apricus. However, it
is necessary to note that the bite of some araneids can result in
severe muscular pains and general discomfort and handling
them should therefore be avoided.
My sincerest thanks to Dr Ansie Dippenaar-Schoeman (ARC-
Plant Protection Research Institute, Pretoria) for identifying the
spider, supplying distribution data and her comments on this
report.
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